Steven Mertens
Chief Technology OfficerMr. Steven Mertens, also known as Steve, has been Chief Technology Officer at NeuroOne Medical Technologies Corporation since April 01, 2019. Mr. Mertens served as Senior Vice President of Operations at Nuvaira, Inc. from November 2012 through September 2018. Mr. Mertens oversees research and development, quality and manufacturing at Holaira. Mr. Mertens has medical device operational experience. He serves as Secretary of LifeScience Alley. Prior to Nuvaira, Mr. Mertens served as a Senior Vice President of Research and Development for Boston Scientific Corporation. He guided a wide range of technologies through product development for the cardiology, electrophysiology and peripheral vascular markets at Boston Scientific. Mr. Mertens served as Vice Chairman of LifeScience Alley since May 2013 and previously served as its Chairman until May 2013. He serves as a Director of LifeScience Alley. From September 2018 through April 2019, Mr. Mertens was a consultant at Steve Mertens Consulting, L.L.C. From September 2018 through April 2019, Mr. Mertens was the principal and owner of Steve Mertens Consulting, L.L.C., where he provided new product development engineering support and assessment services to various clients. He serves as chairman of the board of directors of the University Enterprise Laboratories. He began his medical device career working in engineering, quality control, and manufacturing roles at SciMed Life Sciences. He holds a Bachelor of Science degree in Chemical Engineering from the University of Minnesota and a master’s degree in Business Administration from the University of St. Thomas.
Positions
- Company NameNeuroOne Medical Technologies CorporationStock CodeNMTCPositionChief Technology OfficerColleagues
- DADavid A. RosaPresident, CEO & Director
- PRPaul R. BuckmanIndependent Chairman of the Board
- CRChristopher R. VolkerChief Financial Officer
- RWRonald W. McClurgSenior Advisor
- MCMark ChristiansonCo-Founder, Business Development Director & Medical Sales Liaison
- JSJeffrey S. MathiesenIndependent Director
- GWGreg WorrellChairman of Scientific Advisory Board
- ESEdward S. AndrleIndependent Director
